The prevalence of erythromycin resistance in group B streptococcal isolates at a university hospital in Taiwan

Microbial Drug Resistance

Volumn 14, Issue 4, 2008, Pages 293-297

  Janapatla, Rajendra Prasad ^a   Ho, Yueh Ren ^a   Yan, Jing Jou ^b   Wu, Hsiu Mei ^a,b   Wu, Jiunn Jong ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DNA SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; TAIWAN; UNIVERSITY HOSPITAL;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TAIWAN;

STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP B';

EID: 57749192880     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0853     Document Type: Article

References (21)

1. Amezaga, M.R., P.E. Carter, P. Cash, and H. McKenzie. 2002. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J. Clin. Microbiol. 40:3313-3318.
2. Amyes, S.G. 2007. Enterococci and streptococci. Int. J. Antimicrob. Agents. 29 (Suppl 3):43-52.
3. Biedenbach, D.J., J.M. Stephen, and R.N. Jones. 2003. Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program - North America, 2001. Diagn. Microbiol. Infect. Dis. 46:291-294.
4. Brenciani, A., A. Bacciaglia, M. Vecchi, L.A. Vitali, P.E. Varaldo, and E. Giovanetti. 2007. Genetic elements carrying erm(B) in Streptococcus pyogenes and association with tet(M) tetracycline resistance gene. Antimicrob. Agents Chemother. 51:1209-1216.
5. [CLSI] Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Document M100-S16. CLSI, Wayne, PA.
6. De Azavedo, J.C., M. McGavin, C. Duncan, D.E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
7. Decoster, L., J. Frans, H. Blanckaert, K. Lagrou, and J. Verhaegen. 2005. Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals. Acta Clin. Belg. 60:180-184.
8. Gherardi, G., M. Imperi, L. Baldassarri, M. Pataracchia, G. Alfarone, S. Recchia, G. Orefici, G. Dicuonzo, and R. Creti. 2007. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J. Clin. Microbiol. 45:2909-2916.
9. Goossens, H., M. Ferech, R. Vander Stichele, and M. Elseviers. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
10. Hsueh, P.R., J.M. Shyr, and J.J. Wu. 2006. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Clin. Microbiol. Infect. 12:296-298.
11. Ko, W.C., J.J. Yan, N.Y. Lee, H.M. Wu, and J.J. Wu. 2004. Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in southern Taiwan. Microb. Drug Resist. 10:306-312.
12. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
13. Liu, Y.F., C.H. Wang, R.P. Janapatla, H.M. Fu, H.M. Wu, and J.J. Wu. 2007. Presence of plasmid pA15 correlates with prevalence of constitutive MLS(B) resistance in group A streptococcal isolates at a university hospital in southern Taiwan. J. Antimicrob. Chemother. 59:1167-1170.
14. Persson, E., S. Berg, H. Bergseng, K. Bergh, R. Valsö-Lyng, and B. Trollfors. 2007. Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988-2001. Scand. J. Infect. Dis. 4:1-6.
15. Sambrook, J., and D.W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd edition. Cold Spring Harbor Laboratory Press, New York.
16. Schoening, T.E., J. Wagner, and M. Arvand. 2005. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin. Microbiol. Infect. 11:579-582.
17. Silva-Costa, C., M. Ramirez, and J. Melo-Cristino; Portuguese Surveillance Group for the Study of Respiratory Pathogens. 2005. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob. Agents Chemother. 49:2109-2111.
18. Uh, Y., G.Y. Hwang, I.H. Jang, H.M. Cho, S.M. Noh, H.Y. Kim, O. Kwon, and K.J. Yoon. 2007. Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital. Yonsei Med. J. 48:773-778.
19. Weisner, A.M., A.P. Johnson, T.L. Lamagni, E. Arnold, M. Warner, P.T. Heath, and A. Efstratiou. 2004. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin. Infect. Dis. 38:1203-1208.
20. Yan, J.J., H.M. Wu, A.H. Huang, H.M. Fu, C.T. Lee, and J.J. Wu. 2000. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J. Clin. Microbiol. 38:2475-2479.
21. Zielenkiewicz, U., and P. Ceglowski. 2005. The toxin-antitoxin system of the streptococcal plasmid pSM19035. J. Bacteriol. 187:6094- 6105.